Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;35:68-75

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohnaka, K.
Right arrow Articles by Inagami, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohnaka, K.
Right arrow Articles by Inagami, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Smooth muscle proliferation and differentiation

(Hypertension. 2000;35:68.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Induction of Cyclooxygenase-2 by Angiotensin II in Cultured Rat Vascular Smooth Muscle Cells

Keizo Ohnaka; Kotaro Numaguchi; Tadashi Yamakawa; Tadashi Inagami

From the Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tenn.

Correspondence to Tadashi Inagami, PhD, Department of Biochemistry, Vanderbilt University School of Medicine, 663 Light Hall, Nashville, TN 37232-0146. E-mail inagamit{at}ctrvax.vanderbilt.edu

Abstract—Angiotensin II (Ang II) stimulates the release of prostaglandins (PGs) in various cells and tissues. Recently, cyclooxygenase-2 (COX-2) emerged as a new key regulator for PG synthesis. In the present study, we investigated whether Ang II regulates COX-2 expression in cultured rat vascular smooth muscle cells (VSMCs). Ang II markedly increased the expression of COX-2 mRNA in a time- and dose-dependent manner. This effect was completely blocked by the Ang II type 1 receptor antagonist losartan but not by the Ang II type 2 receptor antagonist PD123319. The p42/44 mitogen-activated protein kinase (MAPK) kinase-1 inhibitor PD98059 and the p38 MAPK inhibitor SB203580 significantly suppressed Ang II–induced COX-2 mRNA and protein expression. Ang II did not increase transcription of the COX-2 gene, as examined with a COX-2 promoter/luciferase chimeric plasmid construct. Instead, it suppressed the degradation of COX-2 mRNA. PD98059 and SB203580 markedly enhanced the decay of COX-2 mRNA induced by Ang II, implying that p42/44 and p38 MAPK activated by Ang II play a role in the regulation of COX-2 through stabilization of its mRNA. The COX-2–specific inhibitor NS-398 attenuated Ang II–stimulated DNA and protein synthesis, as well as PGE2 production by VSMCs. These results suggest that Ang II regulates COX-2 expression and PG production and modulates cell proliferation through MAPK-mediated signaling pathways in rat VSMCs.


Key Words: angiotensin II • cyclooxygenase 2 • protein kinases • muscle, smooth, vascular




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. J. Casal, S. Ryser, A. M. Capponi, and C. F. Wang-Buholzer
Angiotensin II-Induced Mitogen-Activated Protein Kinase Phosphatase-1 Expression in Bovine Adrenal Glomerulosa Cells: Implications in Mineralocorticoid Biosynthesis
Endocrinology, November 1, 2007; 148(11): 5573 - 5581.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Alvarez, J. V. Perez-Giron, R. Hernanz, A. M. Briones, A. Garcia-Redondo, A. Beltran, M. J. Alonso, and M. Salaices
Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive Rats
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 381 - 388.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. A. Morinelli, J. R. Raymond, A. Baldys, Q. Yang, M.-h. Lee, L. Luttrell, and M. E. Ullian
Identification of a putative nuclear localization sequence within ANG II AT1A receptor associated with nuclear activation
Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1398 - C1408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. L. Opay, C. R. Mouton, J. J. Mullins, and K. D. Mitchell
Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension
Am J Physiol Renal Physiol, September 1, 2006; 291(3): F612 - F618.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Qi, H. Cai, J. D. Morrow, and M. D. Breyer
Differentiation of Cyclooxygenase 1- and 2-Derived Prostanoids in Mouse Kidney and Aorta
Hypertension, August 1, 2006; 48(2): 323 - 328.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. L. King, D. B. Trivedi, J. M. Gitlin, and C. D. Loftin
Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1137 - 1143.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A Mezzetti
Pharmacological modulation of plaque instability
Lupus, September 1, 2005; 14(9): 769 - 772.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
Z. Guo, W. Su, S. Allen, H. Pang, A. Daugherty, E. Smart, and M. C. Gong
COX-2 Up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice
Cardiovasc Res, September 1, 2005; 67(4): 723 - 735.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Pullmann Jr., M. Juhaszova, I. L. de Silanes, T. Kawai, K. Mazan-Mamczarz, M. K. Halushka, and M. Gorospe
Enhanced Proliferation of Cultured Human Vascular Smooth Muscle Cells Linked to Increased Function of RNA-binding Protein HuR
J. Biol. Chem., June 17, 2005; 280(24): 22819 - 22826.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. K. K. Sheares, T. K. Jeffery, L. Long, X. Yang, and N. W. Morrell
Differential effects of TGF-{beta}1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L919 - L927.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Drenjancevic-Peric and J. H. Lombard
Introgression of chromosome 13 in Dahl salt-sensitive genetic background restores cerebral vascular relaxation
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H957 - H962.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. L. Therland, J. Stubbe, H. C. Thiesson, P. D. Ottosen, S. Walter, G. L. Sorensen, O. Skott, and B. L. Jensen
Cycloxygenase-2 Is Expressed in Vasculature of Normal and Ischemic Adult Human Kidney and Is Colocalized with Vascular Prostaglandin E2 EP4 Receptors
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1189 - 1198.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Cipollone, M. Fazia, A. Iezzi, B. Pini, C. Cuccurullo, M. Zucchelli, D. de Cesare, S. Ucchino, F. Spigonardo, M. De Luca, et al.
Blockade of the Angiotensin II Type 1 Receptor Stabilizes Atherosclerotic Plaques in Humans by Inhibiting Prostaglandin E2-Dependent Matrix Metalloproteinase Activity
Circulation, March 30, 2004; 109(12): 1482 - 1488.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Cipollone, B. Rocca, and C. Patrono
Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis
Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 246 - 255.
[Abstract] [Full Text]


Home page
HypertensionHome page
T. Suganami, K. Mori, I. Tanaka, M. Mukoyama, A. Sugawara, H. Makino, S. Muro, K. Yahata, S. Ohuchida, T. Maruyama, et al.
Role of Prostaglandin E Receptor EP1 Subtype in the Development of Renal Injury in Genetically Hypertensive Rats
Hypertension, December 1, 2003; 42(6): 1183 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. A Frias, F. Dubouloz, M. C Rebsamen, and U. Lang
Prostacyclin production in rat aortic smooth muscle cells: role of protein kinase C, phospholipase D and cyclooxygenase-2 expression
Cardiovasc Res, November 1, 2003; 60(2): 438 - 446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Chen, E. V. Balyakina, M. Lawrence, B. W. Christman, and B. Meyrick
Cyclooxygenase is regulated by ET-1 and MAPKs in peripheral lung microvascular smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L614 - L621.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. G. Tessner, F. Muhale, S. Schloemann, S. M. Cohn, A. Morrison, and W. F. Stenson
Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase
Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G269 - G279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
X. Yang, K. K. K. Sheares, N. Davie, P. D. Upton, G. W. Taylor, J. Horsley, J. Wharton, and N. W. Morrell
Hypoxic Induction of Cox-2 Regulates Proliferation of Human Pulmonary Artery Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 688 - 696.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z.-W. Hu, R. Kerb, X.-Y. Shi, T. Wei-Lavery, and B. B. Hoffman
Angiotensin II Increases Expression of Cyclooxygenase-2: Implications for the Function of Vascular Smooth Muscle Cells
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 563 - 573.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Mukai, H. Shimokawa, M. Higashi, K. Morikawa, T. Matoba, J. Hiroki, I. Kunihiro, H. M.A. Talukder, and A. Takeshita
Inhibition of Renin-Angiotensin System Ameliorates Endothelial Dysfunction Associated With Aging in Rats
Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1445 - 1450.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Sadoshima
Novel AT1 Receptor-Independent Functions of Losartan
Circ. Res., April 19, 2002; 90(7): 754 - 756.
[Full Text] [PDF]


Home page
Circ. Res.Home page
C. Kramer, J. Sunkomat, J. Witte, M. Luchtefeld, M. Walden, B. Schmidt, R. H. Boger, W.-G. Forssmann, H. Drexler, and B. Schieffer
Angiotensin II Receptor-Independent Antiinflammatory and Antiaggregatory Properties of Losartan: Role of the Active Metabolite EXP3179
Circ. Res., April 19, 2002; 90(7): 770 - 776.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Mendez and M. C. LaPointe
Trophic Effects of the Cyclooxygenase-2 Product Prostaglandin E2 in Cardiac Myocytes
Hypertension, February 1, 2002; 39(2): 382 - 388.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. M. Reynolds, S. Eguchi, G. D. Frank, and E. D. Motley
Signaling Mechanisms of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Vascular Smooth Muscle Cells
Hypertension, February 1, 2002; 39(2): 525 - 529.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Schnermann
Cyclooxygenase-2 and macula densa control of renin secretion
Nephrol. Dial. Transplant., September 1, 2001; 16(9): 1735 - 1738.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Schwobel, T. Fischer, B. Lanz, and M. Mohaupt
Angiotensin II receptor subtypes determine induced NO production in rat glomerular mesangial cells
Am J Physiol Renal Physiol, December 1, 2000; 279(6): F1092 - F1100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Yang, Y. Endo, Y. G. Huang, A. Smart, J. P. Briggs, and J. Schnermann
Renin expression in COX-2-knockout mice on normal or low-salt diets
Am J Physiol Renal Physiol, November 1, 2000; 279(5): F819 - F825.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Stanke-Labesque, P. Devillier, P. Bedouch, J. L. Cracowski, O. Chavanon, and G. Bessard
Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition
Cardiovasc Res, August 1, 2000; 47(2): 376 - 383.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Hernandez, H. Astudillo, and B. Escalante
Angiotensin II stimulates cyclooxygenase-2 mRNA expression in renal tissue from rats with kidney failure
Am J Physiol Renal Physiol, April 1, 2002; 282(4): F592 - F598.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Kramer, J. Sunkomat, J. Witte, M. Luchtefeld, M. Walden, B. Schmidt, R. H. Boger, W.-G. Forssmann, H. Drexler, and B. Schieffer
Angiotensin II Receptor-Independent Antiinflammatory and Antiaggregatory Properties of Losartan: Role of the Active Metabolite EXP3179
Circ. Res., April 19, 2002; 90(7): 770 - 776.
[Abstract] [Full Text] [PDF]